Previous Article | Next Article ![]()
Journal of Bacteriology, June 1999, p. 3860-3863, Vol. 181, No. 12
Microbiology Unit, Department of
Biochemistry, University of Oxford, Oxford OX1 3QU, United Kingdom
Received 10 November 1998/Accepted 11 April 1999
SpoIIAA, a phosphorylatable protein, is essential to the regulation
of Early in sporulation, Bacillus
subtilis divides asymmetrically to produce a small compartment,
the prespore, and a large compartment, the mother cell. Differential
gene expression in the prespore and the mother cell depends on sigma
factors whose activity is confined to one or other compartment and is
limited temporally (8, 13). The first sporulation-specific
sigma factor, The phenotypes of several strains with spoIIAA mutations
have been described. However, although the corresponding amino acid changes in SpoIIAA are identified, there is for most of the strains no
satisfactory account of the mutant phenotype in molecular terms. One
possible explanation for the phenotype might be that the SpoIIAA proteins made by these mutants differ from wild-type SpoIIAA in their
response to the SpoIIAB kinase or the SpoIIE phosphatase (or both).
Alternatively, the mutant SpoIIAA proteins might differ radically in
structure from the wild type and be unable to fold correctly. The
solution structure of SpoIIAA, a 117-residue protein, has been
published recently (11). It shows a fold consisting of a
four-stranded In this paper we describe studies of the SpoIIAA proteins present in
four mutant strains: strain 42 (SpoIIAAG95D) (18), strain 69 (SpoIIAAG62D) (18), strain 565 (SpoIIAAG20S,S58N) (2), and strain 568 (SpoIIAAG76E) (2). The
incidence of spore formation in strain 42 is about 0.1% of that in the
wild type, while the other three mutants are completely asporogenous (2, 18). Figure 1 shows the
structure of the wild-type protein (11) and the positions of
the residues affected in these mutants.
0021-9193/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Genotype, Phenotype, and Protein Structure in a Regulator of
Sporulation: Effects of Mutations in the spoIIAA Gene of
Bacillus subtilis

and
![]()
ABSTRACT
Top
Abstract
Text
References
F, the first sporulation-specific transcription
factor of Bacillus subtilis. The solution structure of
SpoIIAA has recently been published. Here we examine four mutant
SpoIIAA proteins and correlate their properties with the phenotypes of
the corresponding B. subtilis mutant strains. Two of the
mutations severely disrupted the structure of the protein, a third
greatly diminished the rate of its phosphorylation and abolished
dephosphorylation, and the fourth left phosphorylation unaffected but
reduced the rate of dephosphorylation about 10-fold.
![]()
TEXT
Top
Abstract
Text
References
F, becomes active in the prespore soon
after asymmetric septation and is responsible (directly or indirectly)
for the activation of the remaining sigma factors both in the prespore
and the mother cell (reviewed in reference
19). The activity of
F is regulated
by three proteins, SpoIIAB, SpoIIAA, and SpoIIE. SpoIIAB is an
inhibitor of
F and also a specific protein kinase,
SpoIIAA is the substrate of the kinase, and SpoIIE is a specific
protein phosphatase that hydrolyzes phosphorylated SpoIIAA (reviewed in
reference 19). In the predivisional cell
F is kept in an inactive complex with SpoIIAB (3,
5). Two models have been suggested to account for the liberation
of active
F from this complex (7, 15). These
models, although differing to some extent from one another, both
propose that the activity of
F depends on the
concentration of non-phospho-SpoIIAA in the cell or compartment, which
in turn will depend on the balance between the activities of the
SpoIIAB kinase and the SpoIIE phosphatase.
-sheet and four
-helices, with the site of phosphorylation, Ser-58, at the N terminus of the second helix. In the
publication just referred to (11) tentative suggestions were
made to account for the phenotype of the known SpoIIAA mutations, proposing that the
3-
2 loop (containing the phosphorylation site), the
2-
1 loop, and the
3 helix were all involved in the interaction between SpoIIAA and SpoIIAB.

View larger version (86K):
[in a new window]
FIG. 1.
The structure of SpoIIAA, with the residues whose
mutations are discussed in the text indicated.
Accumulation of wild-type and mutant SpoIIAA proteins in B. subtilis. One possible explanation of the phenotypes of the mutant strain(s) is that the mutant SpoIIAA protein(s) might be misfolded and thus rendered insoluble. To examine this possibility, we grew the wild type and the four spoIIAA mutant strains of B. subtilis, resuspended them in a sporulation medium, took 1-ml samples 2 h later, and harvested the cells by centrifugation. Cell pellets were resuspended in 330 µl of an ice-cold sonication buffer (50 mM Tris-HCl [pH 7.5], 10% glycerol, 5 mM dithiothreitol, 1 mM phenylmethylsulfonyl fluoride) and subjected to sonication (2 by 15 sec) in an ice-water bath. Additional phenylmethylsulfonyl fluoride (to bring the concentration to 2 mM) was added. After centrifugation for 5 min at 10,000 × g, the supernatants were subjected to electrophoresis on sodium dodecyl sulfate-polyacrylamide (15%) gels and immunoblotted with purified anti-SpoIIAA antibodies (9). The blots showed that the soluble fraction of wild-type cells and that of the cells carrying SpoIIAAG62D or SpoIIAAG95D contained substantial quantities of SpoIIAA (Fig. 2). By contrast, in the soluble fraction of the mutants with SpoIIAAG20S,S58N or SpoIIAAG76E, SpoIIAA was barely detectable (Fig. 2). When these experiments were repeated with sonicated cells that had not been fractionated by centrifugation, mutant SpoIIAA was found in the strains with SpoIIAAG20S,S58N or SpoIIAAG76E, but in both strains the quantity of SpoIIAA present was only 10 to 20% of that in the cells with SpoIIAA+, SpoIIAAG62D, or SpoIIAAG95D (results not shown). (The previously published results in which SpoIIAA was detected in strains with SpoIIAAG20S,S58N or SpoIIAAG76E [2] failed to distinguish between the soluble and insoluble fractions of the cell.) We concluded that when SpoIIAAG20S,S58N and SpoIIAAG76E are made in B. subtilis, a certain quantity of these mutant proteins accumulates in an insoluble form but that most is degraded. We presume that this degradation is by the B. subtilis equivalents of the Escherichia coli proteases that are responsible for the proteolysis of misfolded proteins (10).
|
Overproduction and purification of the mutant proteins.
We
overproduced the mutant SpoIIAA proteins in E. coli to study
their biochemical properties. PCR was used to amplify the spoIIAA gene from the four mutant strains of B. subtilis. Each PCR product was cloned into expression vector
pET-3a (Novagen), the DNA sequence was verified, and the mutant
spoIIAA was overexpressed in E. coli BL21(DE3)
after induction with IPTG
(isopropyl-
-D-thiogalactopyranoside). The total
quantities of mutant proteins produced were, in all cases, comparable
with that of the wild-type protein. The mutant proteins
SpoIIAAG95D and SpoIIAAG62D were readily purified from the soluble cell
extract by the procedure developed previously in this laboratory, which
yields SpoIIAA at a purity greater than 95% (4). By
contrast, SpoIIAAG20S,S58N and SpoIIAAG76E accumulated in the
overproducing cells in inclusion bodies, and this behavior persisted
even when the temperature of growth after induction with IPTG was
varied between room temperature and 37°C. SpoIIAAG20S,S58N and
SpoIIAAG76E were solubilized from inclusion bodies with 6 M guanidine
hydrochloride. The proteins were refolded by a gradual dilution of the
guanidine to 0.09 M. After the proteins had been adsorbed on
DEAE-Sepharose and eluted with a buffer containing 300 mM NaCl, gel
filtration of these two proteins on Superdex 75 showed that both of
them were excluded from the gel and therefore that their estimated
Mr was greater than 70 kDa. The
Mr of the wild-type protein is 13 kDa, and it is
known to be monomeric. We concluded that the structures of
SpoIIAAG20S,S58N and SpoIIAAG76E had been altered in such a way as to
cause the proteins to aggregate. A further indication of this
aggregation came from electrophoresis of purified
SpoIIAAG20S,S58N and SpoIIAAG76E on a 10% native gel, which
showed in each case a ladder of multiple bands.
Accounting for the phenotypes of strain 565 and strain 568.
The results suggest that strains 565 and 568 contain little or no
soluble SpoIIAA. Lacking an alternative binding partner in these
strains, SpoIIAB will bind exclusively to
F, and
F activity will be totally inhibited. Strains carrying
the doubly mutant protein SpoIIAAG20S,S58N show no detectable
expression of the two
F-dependent genes gpr
and spoIIIG and are partially complemented by the wild-type
spoIIAA gene (2). By contrast the single mutation leading to the replacement S58N is dominant to the wild type, strains
with this mutation express gpr and spoIIIG to a
small but perceptible extent (2), and a SpoIIAA protein
containing the single substitution S58N is soluble and easily purified
(12). It is clear therefore that in the doubly mutant
strain, it is G20S that causes the protein to be misfolded and deprives
it of normal function.
Phosphorylation of the mutant proteins catalyzed by
SpoIIAB.
SpoIIAB catalyzes the phosphorylation of wild-type
SpoIIAA by ATP (16) in a reaction in which the phosphate
is transferred to Ser-58 of the substrate (17). To see how
SpoIIAAG62D and SpoIIAAG95D responded in this reaction, we incubated
each of them with SpoIIAB and [
-32P]ATP and monitored
the incorporation of the labelled phosphate into acid-insoluble
material, as described earlier (15). As Fig.
3A shows, SpoIIAAG95D was
indistinguishable from wild-type SpoIIAA in its response to the SpoIIAB
protein kinase. We have previously reported that the time course of
phosphorylation was biphasic for wild-type SpoIIAA (see reference
15), and we note that the same is true of
SpoIIAAG95D (Fig. 3A). By contrast, SpoIIAAG62D was phosphorylated very
slowly, with an apparent velocity constant about one-half of that for
the steady-state phosphorylation of wild-type SpoIIAA (Fig. 3B). It is
probably relevant that residue 62 is one turn of an
-helix from S58,
the residue that is phosphorylated in this reaction (17). We
suggest that the presence of a negatively charged residue at position
62 hampers the phosphorylation of SpoIIAA by SpoIIAB, as predicted
previously (11).
|
Hydrolysis of the phosphorylated mutant SpoIIAA proteins by SpoIIE. A method for overproducing and purifying full-length SpoIIE from E. coli has been developed recently (14). This SpoIIE preparation achieves a rapid and complete hydrolysis of phosphorylated wild-type SpoIIAA (14), a reaction that can be monitored by taking advantage of the difference in mobility between free and phosphorylated SpoIIAA on nondenaturing gels. To see how the SpoIIAA mutants behaved in this assay, we prepared phosphorylated samples of wild-type SpoIIAA and of the two mutant proteins SpoIIAAG62D and SpoIIAAG95D, by incubating each of the three purified proteins with a one-sixth molar ratio of SpoIIAB in the presence of excess ATP and then removing the ATP and SpoIIAB by gel filtration over Superdex 75. We exposed the purified phosphorylated SpoIIAA proteins to SpoIIE in a 30-µl mixture containing 3 µl of a 10× dephosphorylation buffer (1 M Tris-HCl [pH 7.5], 500 mM NaCl, 10 mM dithiothreitol, 10 mM MnCl2) at 30°C and monitored the appearance of the nonphosphorylated products by running the reaction mixtures on 10% nondenaturing polyacrylamide gels.
The results (Fig. 4) show a striking difference in the rate of hydrolysis between the phosphorylated wild-type protein and phosphorylated SpoIIAAG95D (note the difference in the time scale of the experiment with the wild-type protein and the experiments with the mutant proteins). Still more strikingly, no hydrolysis of phosphorylated SpoIIAAG62D could be detected, even after overnight incubation with SpoIIE (Fig. 4C). To confirm that these differences in the rate of hydrolysis were not due to the adventitious presence of small quantities of SpoIIAB kinase in the phosphorylated SpoIIAA preparations, we ran samples of phosphorylated wild-type SpoIIAA and of each of the phosphorylated mutant SpoIIAA proteins on a sodium dodecyl sulfate gel and probed the gel by Western immunoblotting with an anti-SpoIIAB antibody. No SpoIIAB was found, whereas 50 ng of SpoIIAB run in a neighboring lane was easily detected (results not shown). We conclude that the differences in the rate of hydrolysis of the phosphorylated proteins are a genuine characteristic of these proteins. We surmise that the face of the protein on which both G62 and G95 lie (Fig. 1) may be involved in the interaction with SpoIIE and that a negative charge at residue 62 may abolish the reaction in which a phosphate group attached to S58 is cleaved.
|
Accounting for the phenotype of strain 69.
The results shown
in Fig. 3B suggest that SpoIIAAG62D will be a substrate for the kinase
activity of SpoIIAB in the predivisional cell. When SpoIIAB acts
on wild-type SpoIIAA, a given quantity of SpoIIAB phosphorylates
an equimolar quantity of SpoIIAA in approximately 20 min at 30°C
(15) and therefore, presumably, in about 10 min at 37°C.
The kcat for SpoIIAB in phosphorylating SpoIIAAG62D is about two times less than that for wild-type SpoIIAA (Fig. 3B), but since the intracellular concentration of SpoIIAA in the
predivisional cell is less than that of SpoIIAB (15), we
could expect that by the time of asymmetric septation, all of the
SpoIIAAG62D protein in the cell will be phosphorylated. Thereafter all
the SpoIIAB will be available to inhibit
F. After
asymmetric septation SpoIIAAG62D will all remain in the phosphorylated
form, since it is not a substrate for SpoIIE, and therefore no
SpoIIAA will be available to liberate
F from the complex
with SpoIIAB. In these respects, SpoIIAAG62D resembles the
SpoIIAAS58T protein (carrying a mutation at the phosphorylation site)
described by Duncan et al. (6, 7), which is a substrate for
phosphorylation by the SpoIIAB kinase but whose phosphorylated form
cannot be hydrolyzed by SpoIIE. The complete absence of active
F from strain 69 would then account for its
unequivocally Spo
phenotype.
Accounting for the phenotype of strain 42.
In cells with
SpoIIAAG95D the SpoIIAA protein is phosphorylated by SpoIIAB as rapidly
as in the wild type (Fig. 3A), with the result that, as described for
cells with SpoIIAAG62D,
F will be inhibited in the
predivisional cell. After asymmetric septation, the phosphorylated
SpoIIAAG95D will become a substrate for hydrolysis by SpoIIE. But since
hydrolysis is extremely slow (Fig. 4B), nonphosphorylated SpoIIAA will
be made available at a very low rate. Consequently very little of the
F will be activated
just enough to lead to the
formation of a few spores in this mutant strain.
Conclusion.
The phenotypes of all four of the
spoIIAA mutants studied here can be explained in terms of
the three factors mentioned at the beginning of this paper
changes in
protein folding, changes in response to SpoIIAB, and changes in
response to SpoIIE. The results of the analysis of strains 69 and 42 clearly demonstrate the importance of both phosphorylation and
dephosphorylation of SpoIIAA in the regulation of
F and
point the way to detailed investigations of the SpoIIAA protein by
means of site-directed mutagenesis.
| |
ACKNOWLEDGMENTS |
|---|
Daniela Barillà and Isabelle Lucet contributed equally to this work.
We thank Julie Wickson for outstanding technical assistance, D. Comfort for an analysis of the ability of the SpoIIAA structure to tolerate the changes described here, J. Errington for valuable discussions, and R. Losick for helpful comments on the manuscript.
We acknowledge the Biotechnology and Biological Sciences Research Council for financial support.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Microbiology Unit, Department of Biochemistry, University of Oxford, South Parks Rd., Oxford OX1 3QU, United Kingdom. Phone: 44 1865 275302. Fax: 44 1865 275297. E-mail: mdy{at}bioch.ox.ac.uk.
Present address: Sir William Dunn School of Pathology, University
of Oxford, Oxford OX1 3RE, United Kingdom.
Present address: Philipps-Universität Marburg, Fachbereich
Biologie, Laboratorium für Mikrobiologie, D-35032 Marburg, Germany.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Alper, S., L. Duncan, and R. Losick. 1994. An adenosine nucleotide switch controlling the activity of a cell type-specific transcription factor in B. subtilis. Cell 77:195-205[Medline]. |
| 2. |
Challoner-Courtney, I. J., and M. D. Yudkin.
1993.
Molecular and phenotypic characterization of promoter-proximal mutations in the spoIIA locus of Bacillus subtilis.
J. Bacteriol.
175:5636-5641 |
| 3. |
Decatur, A. L., and R. Losick.
1996.
Three sites of contact between the Bacillus subtilis transcription factor F and its antisigma factor SpoIIAB.
Genes Dev.
10:2348-2358 |
| 4. |
Diederich, B.,
J. F. Wilkinson,
T. Magnin,
S. M. A. Najafi,
J. Errington, and M. D. Yudkin.
1994.
Role of interactions between SpoIIAA and SpoIIAB in regulating cell-specific transcription factor F of Bacillus subtilis.
Genes Dev.
8:2653-2663 |
| 5. |
Duncan, L., and R. Losick.
1993.
SpoIIAB is an anti- factor that binds to and inhibits transcription by regulatory protein F from Bacillus subtilis.
Proc. Natl. Acad. Sci. USA
90:2325-2329 |
| 6. |
Duncan, L.,
S. Alper,
F. Arigoni,
R. Losick, and P. Stragier.
1995.
Activation of cell-specific transcription by a serine phosphatase at the site of asymmetric division.
Science
270:641-644 |
| 7. |
Duncan, L.,
S. Alper, and R. Losick.
1996.
SpoIIAA governs the release of the cell-type specific transcription factor F from its anti-sigma factor SpoIIAB.
J. Mol. Biol.
260:147-164[Medline].
|
| 8. |
Errington, J.
1993.
Bacillus subtilis sporulation: regulation of gene expression and control of morphogenesis.
Microbiol. Rev.
57:1-33 |
| 9. |
Feucht, A.,
T. Magnin,
M. D. Yudkin, and J. Errington.
1996.
Bifunctional protein required for asymmetric cell division and cell-specific transcription in Bacillus subtilis.
Genes Dev.
10:794-803 |
| 10. | Gross, C. A. 1996. Function and regulation of the heat shock proteins, p. 1382-1399. In F. C. Neidhardt, R. Curtiss III, J. L. Ingraham, E. C. C. Lin, K. B. Low, B. Magasanik, W. S. Reznikoff, M. Riley, M. Schaechter, and H. E. Umbarger (ed.), Escherichia coli and Salmonella: cellular and molecular biology, 2nd ed. ASM Press, Washington, D.C. |
| 11. |
Kovacs, H.,
D. Comfort,
M. Lord,
I. D. Campbell, and M. D. Yudkin.
1998.
Solution structure of SpoIIAA, a phosphorylatable component of the system that regulates transcription factor F of Bacillus subtilis.
Proc. Natl. Acad. Sci. USA
95:5067-5071 |
| 12. |
Lord, M.,
T. Magnin, and M. D. Yudkin.
1996.
Protein conformational change and nucleotide binding involved in regulation of F in Bacillus subtilis.
J. Bacteriol.
178:6730-6735 |
| 13. | Losick, R., and P. Stragier. 1992. Crisscross regulation of cell-type-specific gene expression during development in B. subtilis. Nature 355:601-604[Medline]. |
| 14. |
Lucet, I.,
R. Borriss, and M. D. Yudkin.
1999.
Purification, kinetic properties, and intracellular concentration of SpoIIE, an integral membrane protein that regulates sporulation in Bacillus subtilis.
J. Bacteriol.
181:3242-3245 |
| 15. |
Magnin, T.,
M. Lord, and M. D. Yudkin.
1997.
Contribution of partner switching and SpoIIAA cycling to regulation of F activity in Bacillus subtilis.
J. Bacteriol.
179:3922-3927 |
| 16. |
Min, K.-T.,
C. M. Hilditch,
B. Diederich,
J. Errington, and M. D. Yudkin.
1993.
F, the first compartment-specific transcription factor of Bacillus subtilis, is regulated by an anti- factor that is also a protein kinase.
Cell
74:735-742[Medline].
|
| 17. |
Najafi, S. M. A.,
A. C. Willis, and M. D. Yudkin.
1995.
Site of phosphorylation of SpoIIAA, the anti-anti-sigma factor for sporulation-specific F of Bacillus subtilis.
J. Bacteriol.
177:2912-2913 |
| 18. |
Piggot, P. J.
1973.
Mapping of asporogenous mutations of Bacillus subtilis: a minimum estimate of the number of sporulation operons.
J. Bacteriol.
114:1241-1253 |
| 19. | Stragier, P., and R. Losick. 1996. Molecular genetics of sporulation in Bacillus subtilis. Annu. Rev. Genet. 30:297-341[Medline]. |
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»